|
|
Human microbiome and prostate cancer development: current insights into the prevention and treatment |
Solmaz Ohadian Moghadam(), Seyed Ali Momeni |
Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran |
|
|
Abstract The huge communities of microorganisms that symbiotically colonize humans are recognized as significant players in health and disease. The human microbiome may influence prostate cancer development. To date, several studies have focused on the effect of prostate infections as well as the composition of the human microbiome in relation to prostate cancer risk. Current studies suggest that the microbiota of men with prostate cancer significantly differs from that of healthy men, demonstrating that certain bacteria could be associated with cancer development as well as altered responses to treatment. In healthy individuals, the microbiome plays a crucial role in the maintenance of homeostasis of body metabolism. Dysbiosis may contribute to the emergence of health problems, including malignancy through affecting systemic immune responses and creating systemic inflammation, and changing serum hormone levels. In this review, we discuss recent data about how the microbes colonizing different parts of the human body including urinary tract, gastrointestinal tract, oral cavity, and skin might affect the risk of developing prostate cancer. Furthermore, we discuss strategies to target the microbiome for risk assessment, prevention, and treatment of prostate cancer.
|
Keywords
microbiome
prostate cancer
prevention
treatment
molecular pathological epidemiology (MPE)
biomarker
|
Corresponding Author(s):
Solmaz Ohadian Moghadam
|
Just Accepted Date: 21 January 2020
Online First Date: 30 June 2020
Issue Date: 11 February 2021
|
|
1 |
RL Siegel, KD Miller, A Jemal. Cancer statistics, 2018. CA Cancer J Clin 2018; 68(1): 7–30
https://doi.org/10.3322/caac.21442
pmid: 29313949
|
2 |
MM Center, A Jemal, J Lortet-Tieulent, E Ward, J Ferlay, O Brawley, F Bray. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012; 61(6): 1079–1092
https://doi.org/10.1016/j.eururo.2012.02.054
pmid: 22424666
|
3 |
T Kimura, S Egawa. Epidemiology of prostate cancer in Asian countries. Int J Urol 2018; 25: 524–531
https://doi.org/10.1111/iju.13593
|
4 |
MR Nowroozi, SA Momeni, S Ohadian Moghadam, E Ayati, A Mortazavi, S Arfae, H Jamshidian, M Taherimahmoudi, M Ayati. Prostate-specific antigen density and gleason score predict adverse pathologic features in patients with clinically localized prostate cancer. Nephrourol Mon Nephrourol Mon 2016; 8(6): e39984
https://doi.org/10.5812/numonthly.39984
pmid: 27896239
|
5 |
F Moradpour, Z Fatemi. Estimation of the projections of the incidence rates, mortality and prevalence due to common cancer site in Isfahan, Iran. Asian Pac J Cancer Prev 2013; 14(6): 3581–3585
https://doi.org/10.7314/APJCP.2013.14.6.3581
pmid: 23886149
|
6 |
KS Sfanos, WB Isaacs, AM De Marzo. Infections and inflammation in prostate cancer. Am J Clin Exp Urol 2013; 1(1): 3–11
pmid: 25110720
|
7 |
SF Peisch, EL Van Blarigan, JM Chan, MJ Stampfer, SA Kenfield. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol 2017; 35(6): 867–874
https://doi.org/10.1007/s00345-016-1914-3
pmid: 27518576
|
8 |
PJ Turnbaugh, RE Ley, M Hamady, CM Fraser-Liggett, R Knight, JI Gordon. The human microbiome project. Nature 2007; 449(7164): 804–810
https://doi.org/10.1038/nature06244
pmid: 17943116
|
9 |
N Uemura, S Okamoto, S Yamamoto, N Matsumura, S Yamaguchi, M Yamakido, K Taniyama, N Sasaki, RJ Schlemper. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345(11): 784–789
https://doi.org/10.1056/NEJMoa001999
pmid: 11556297
|
10 |
A Sheh, JG Fox. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes 2013; 4(6): 505–531
https://doi.org/10.4161/gmic.26205
pmid: 23962822
|
11 |
AK DeGruttola, D Low, A Mizoguchi, E Mizoguchi. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis 2016; 22(5): 1137–1150
https://doi.org/10.1097/MIB.0000000000000750
pmid: 27070911
|
12 |
AV Hartstra, KE Bouter, F Bäckhed, M Nieuwdorp. Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 2015; 38(1): 159–165
https://doi.org/10.2337/dc14-0769
pmid: 25538312
|
13 |
F Carbonero, AC Benefiel, AH Alizadeh-Ghamsari, HR Gaskins. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol 2012; 3: 448
https://doi.org/10.3389/fphys.2012.00448
pmid: 23226130
|
14 |
MM Huycke, HR Gaskins. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 2004; 229(7): 586–597
https://doi.org/10.1177/153537020422900702
pmid: 15229352
|
15 |
X Wang, MM Huycke. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 2007; 132(2): 551–561
https://doi.org/10.1053/j.gastro.2006.11.040
pmid: 17258726
|
16 |
X Wang, Y Yang, DR Moore, SL Nimmo, SA Lightfoot, MM Huycke. 4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by enterococcus faecalis-infected macrophages. Gastroenterology 2012; 142: 543–551
https://doi.org/10.1053/j.gastro.2011.11.020
|
17 |
D Nesić, Y Hsu, CE Stebbins. Assembly and function of a bacterial genotoxin. Nature 2004; 429: 429–433
https://doi.org/10.1038/nature02532
|
18 |
W Liang, N Ferrara. The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol Res 2016; 4: 83–91
https://doi.org/10.1158/2326-6066.CIR-15-0313
|
19 |
K Mima, Y Cao, AT Chan, ZR Qian, JA Nowak, Y Masugi, et al.. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin Transl Gastroenterol 2016; 7: e200
https://doi.org/10.1038/ctg.2016.53
|
20 |
A Cougnoux, G Dalmasso, R Martinez, E Buc, J Delmas, L Gibold, et al.. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 2014; 63: 1932–1942
https://doi.org/10.1136/gutjnl-2013-305257.
|
21 |
Q Zhang, N Yu, C Lee. Mysteries of TGF-β paradox in benign and malignant cells. Front Oncol 2014; 4: 94
https://doi.org/10.3389/fonc.2014.00094
|
22 |
BE Menzies. The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis 2003; 16: 225–229
https://doi.org/10.1097/01.qco.0000073771.11390.75
|
23 |
N Li, A Ren, X Wang, X Fan, Y Zhao, GF Gao, P Cleary, B Wang. Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors. Proc Natl Acad Sci USA 2015; 112(1): 238–243
https://doi.org/10.1073/pnas.1414422112
pmid: 25535343
|
24 |
SB Jakowlew. Transforming growth factor-β in cancer and metastasis. Cancer Metastasis Rev 2006; 25(3): 435–457
https://doi.org/10.1007/s10555-006-9006-2
|
25 |
DG Bostwick, G de la Roza, P Dundore, FA Corica, KA Iczkowski. Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate 2003; 55: 187–193
https://doi.org/10.1002/pros.10224
|
26 |
D Dikov, S Bachurska, D Staikov, V Sarafian. Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate. Prostate 2015; 75(10): 1074–1084
https://doi.org/10.1002/pros.22991
pmid: 25917232
|
27 |
T Fujii, K Shimada, O Asai, N Tanaka, K Fujimoto, K Hirao, N Konishi. Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostate. Pathobiology 2013; 80(3): 119–126
https://doi.org/10.1159/000342396
pmid: 23328608
|
28 |
KS Sfanos, S Yegnasubramanian, WG Nelson, AM De Marzo. The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol 2018; 15: 11–24
https://doi.org/10.1038/nrurol.2017.167
|
29 |
E Shrestha, JR White, SH Yu, I Kulac, O Ertunc, AM De Marzo, S Yegnasubramanian, LA Mangold, AW Partin, KS Sfanos. Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J Urol 2018; 199(1): 161–171
https://doi.org/10.1016/j.juro.2017.08.001
pmid: 28797714
|
30 |
R Virchow. An address on the value of pathological experiments. Br Med J 1881; 2(1075): 198–203
https://doi.org/10.1136/bmj.2.1075.198
|
31 |
SI Grivennikov, FR Greten, M Karin. Immunity, inflammation, and cancer. Cell 2010; 140(6): 883–899
https://doi.org/10.1016/j.cell.2010.01.025
|
32 |
NB Delongchamps, G de la Roza, V Chandan, R Jones, R Sunheimer, G Threatte, et al.. Evaluation of prostatitis in autopsied prostates—is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol 2008; 179(5): 1736–1740
https://doi.org/10.1016/j.juro.2008.01.034
|
33 |
T Stark, L Livas, N Kyprianou. Inflammation in prostate cancer progression and therapeutic targeting. Transl Androl Urol 2015; 4(4): 455–463
https://doi.org/10.3978/j.issn.2223-4683.2015.04.12
|
34 |
CL Maynard, CO Elson, RD Hatton, CT Weaver. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012; 489(7415): 231–241
https://doi.org/10.1038/nature11551
|
35 |
H Goris, F de Boer, D van der Waaij. Myelopoiesis in experimentally contaminated specific-pathogen-free and germfree mice during oral administration of polymyxin. Infect Immun 1985; 50(2): 437–441
pmid: 2997040
|
36 |
A Khosravi, A Yáñez, JG Price, A Chow, M Merad, HS Goodridge, et al.. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 2014; 15(3): 374–381
https://doi.org/10.1016/j.chom.2014.02.006
|
37 |
RF Schwabe, C Jobin. The microbiome and cancer. Nat Rev Cancer 2013; 13(11): 800–812
https://doi.org/10.1038/nrc3610
|
38 |
AM Sheflin, AK Whitney, TL Weir. Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep 2014; 16(10): 406
https://doi.org/10.1007/s11912-014-0406-0
|
39 |
C Horbinski, C Mojesky, N Kyprianou. Live free or die: tales of homeless (cells) in cancer. Am J Pathol 2010; 177: 1044–1052
https://doi.org/10.2353/ajpath.2010.091270
|
40 |
MR Galdiero, E Bonavita, I Barajon, C Garlanda, A Mantovani, S Jaillon. Tumor associated macrophages and neutrophils in cancer. Immunobiology 2013; 218(11): 1402–1410
https://doi.org/10.1016/j.imbio.2013.06.003
|
41 |
M Puhr, A De Marzo, W Isaacs, MS Lucia, K Sfanos, S Yegnasubramanian, et al.. Inflammation, microbiota, and prostate cancer. Eur Urol Focus 2016; 2(4): 374–382
https://doi.org/10.1016/j.euf.2016.08.010
|
42 |
DA Barron, DR Rowley. The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer 2012; 19(6): R187–204
https://doi.org/10.1530/ERC-12-0085
|
43 |
SM Frisch, RA Screaton. Anoikis mechanisms. Curr Opin Cell Biol 2001; 13(5): 555–562
https://doi.org/10.1016/S0955-0674(00)00251-9
pmid: 11544023
|
44 |
H Armstrong, M Bording-Jorgensen, S Dijk, E Wine. The complex interplay between chronic inflammation, the microbiome, and cancer: understanding disease progression and what we can do to prevent it. Cancers (Basel) 2018; 10(3): 83
https://doi.org/10.3390/cancers10030083
|
45 |
F Balkwill, A Mantovani. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539–545
https://doi.org/10.1016/S0140-6736(00)04046-0
|
46 |
LM Coussens, Z Werb. Inflammation and cancer. Nature 2002; 420(6917): 860–867
https://doi.org/10.1038/nature01322
|
47 |
F Colotta, P Allavena, A Sica, C Garlanda, A Mantovani. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009; 30(7): 1073–1081
https://doi.org/10.1093/carcin/bgp127
|
48 |
R Francescone, V Hou, SI Grivennikov. Microbiome, inflammation, and cancer. Cancer J 2014; 20(3): 181–189
https://doi.org/10.1097/PPO.0000000000000048
|
49 |
A Dzutsev, JH Badger, E Perez-Chanona, S Roy, R Salcedo, CK Smith, G Trinchieri. Microbes and cancer. Annu Rev Immunol 2017; 35(1): 199–228
https://doi.org/10.1146/annurev-immunol-051116-052133
pmid: 28142322
|
50 |
PH Schatteman, L Hoekx, JJ Wyndaele, W Jeuris, E Van Marck. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 2000; 37(4): 404–412
https://doi.org/10.1159/000020161
|
51 |
B Gurel, MS Lucia, IM Jr Thompson, PJ Goodman, CM Tangen, AR Kristal, et al.. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2014; 23(5): 847–856
https://doi.org/10.1158/1055-9965.EPI-13-1126
|
52 |
C De Nunzio, G Kramer, M Marberger, R Montironi, W Nelson, F Schröder, et al.. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 2011; 60(1): 106–117
https://doi.org/10.1016/j.eururo.2011.03.055
|
53 |
DB Shinohara, AM Vaghasia, SH Yu, TN Mak, H Brüggemann, WG Nelson, et al.. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate 2013; 73(9): 1007–1015
https://doi.org/10.1002/pros.22648
|
54 |
JE Elkahwaji, W Zhong, WJ Hopkins, W Bushman. Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 2007; 67(1): 14–21
https://doi.org/10.1002/pros.20445
|
55 |
PS Pelouze. Gonorrhea in the male and female: a book for practitioners. Philadelphia: W. B. Saunders Company, 1935
|
56 |
F Poletti, MC Medici, A Alinovi, MG Menozzi, P Sacchini, G Stagni, et al.. Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis. J Urol 1985; 134(4): 691–693
https://doi.org/10.1016/s0022-5347(17)47387-3
|
57 |
RB Hayes, LM Pottern, H Strickler, C Rabkin, V Pope, GM Swanson, et al.. Sexual behavior, STDs and risks for prostate cancer. Br J Cancer 2000; 82(3): 718–725
https://doi.org/10.1054/bjoc.1999.0986
|
58 |
H Maeda, T Akaike. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 1998; 63(7): 854–865
pmid: 9721338
|
59 |
AM De Marzo, EA Platz, S Sutcliffe, J Xu, H Grönberg, CG Drake, Y Nakai, WB Isaacs, WG Nelson. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7(4): 256–269
https://doi.org/10.1038/nrc2090
|
60 |
SJ Bultman. Emerging roles of the microbiome in cancer. Carcinogenesis 2014; 35(2): 249–255
https://doi.org/10.1093/carcin/bgt392
|
61 |
CM Buchta Rosean, MR Rutkowski. The influence of the commensal microbiota on distal tumor-promoting inflammation. Semin Immunol 2017; 32: 62–73
https://doi.org/10.1016/j.smim.2017.06.002
|
62 |
M Schirmer, SP Smeekens, H Vlamakis, M Jaeger, M Oosting, EA Franzosa, et al.. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 2016; 167(4): 1125–1136.e8
https://doi.org/10.1016/j.cell.2016.10.020
|
63 |
WM Chu. Tumor necrosis factor. Cancer Lett 2013; 328: 222–225
https://doi.org/10.1016/j.canlet.2012.10.014
|
64 |
J Suh, AB Rabson. NF-κB activation in human prostate cancer: important mediator or epiphenomenon? J Cell Biochem 2004; 91: 100–117
https://doi.org/10.1002/jcb.10729
|
65 |
CH Lee, YT Jeon, SH Kim, YS Song. NF-κB as a potential molecular target for cancer therapy. Biofactors 2007; 29(1): 19–35
https://doi.org/10.1002/biof.5520290103
pmid: 17611291
|
66 |
S Ohadian Moghadam, MR Nowroozi. Toll-like receptors: the role in bladder cancer development, progression and immunotherapy. Scand J Immunol 2019: e12818
https://doi.org/10.1111/sji.12818
|
67 |
JH Harmey, CD Bucana, W Lu, AM Byrne, S McDonnell, C Lynch, et al.. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer 2002; 101(5): 415–422
https://doi.org/10.1002/ijc.10632
|
68 |
F Simon, R Fernández. Early lipopolysaccharide-induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells. J Hypertens. 2009; 27(6): 1202–1216
https://doi.org/10.1097/HJH.0b013e328329e31c
|
69 |
XL Xu, RT Lee, HM Fang, YM Wang, R Li, H Zou, Y Zhu, Y Wang. Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p. Cell Host Microbe 2008; 4(1): 28–39
https://doi.org/10.1016/j.chom.2008.05.014
|
70 |
ML Maneval, KA Eckert. Effects of oxidative and alkylating damage on microsatellite instability in nontumorigenic human cells. Mutat Res 2004; 546: 29–38
https://doi.org/10.1016/j.mrfmmm.2003.10.001
|
71 |
AK Cheema, I Maier, T Dowdy, Y Wang, R Singh, PM Ruegger, et al.. Chemopreventive metabolites are correlated with a change in intestinal microbiota measured in A-T mice and decreased carcinogenesis. PLoS One 2016; 11: e0151190
https://doi.org/10.1371/journal.pone.0151190
|
72 |
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486(7402): 207–214
https://doi.org/10.1038/nature11234
pmid: 22699609
|
73 |
TA van der Meulen, H Harmsen, H Bootsma, F Spijkervet, F Kroese, A Vissink. The microbiome-systemic diseases connection. Oral Dis 2016; 22(8): 719–734
https://doi.org/10.1111/odi.12472
pmid: 26953630
|
74 |
O Pabst. Correlation, consequence, and functionality in microbiome-immune interplay. Immunol Rev 2017; 279(1): 4–7
https://doi.org/10.1111/imr.12584
pmid: 28856741
|
75 |
M Arumugam, J Raes, E Pelletier, D Le Paslier, T Yamada, DR Mende, et al.. Enterotypes of the human gut microbiome. Nature 2011; 473: 174–180
https://doi.org/10.1038/nature09944
|
76 |
E Rinninella, P Raoul, M Cintoni, F Franceschi, GAD Miggiano, A Gasbarrini, et al.. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 2019; 7(1): 14
https://doi.org/10.3390/microorganisms7010014
|
77 |
C Huggins, CV Hodges. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 2002; 167(2 Pt 2): 948–952
https://doi.org/10.1016/S0022-5347(02)80307-X
pmid: 11905923
|
78 |
FJ Strobl, JE Levine. Estrogen inhibits luteinizing hormone (LH), but not follicle-stimulating hormone secretion in hypophysectomized pituitary-grafted rats receiving pulsatile LH-releasing hormone infusions. Endocrinology 1988; 123(1): 622–630
https://doi.org/10.1210/endo-123-1-622
|
79 |
R Geier, S Adler, G Rashid, A Klein. The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells. Prostate 2010; 70(12): 1307–1312
https://doi.org/10.1002/pros.21166
|
80 |
P Thelen, W Wuttke, H Jarry, M Grzmil, RH Ringert. Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells. J Urol 2004; 171(5): 1934–1938
https://doi.org/10.1097/01.ju.0000121329.37206.1b
|
81 |
CS Plottel, MJ Blaser. Microbiome and malignancy. Cell Host Microbe 2011; 10: 324–335
https://doi.org/10.1016/j.chom.2011.10.003
|
82 |
E Cavalieri, D Chakravarti, J Guttenplan, E Hart, J Ingle, R Jankowiak, P Muti, E Rogan, J Russo, R Santen, T Sutter. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 2006; 1766(1): 63–78
https://doi.org/10.1016/j.bbcan.2006.03.001
pmid: 16675129
|
83 |
JM Baker, L Al-Nakkash, MM Herbst-Kralovetz. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas 2017; 103: 45–53
https://doi.org/10.1016/j.maturitas.2017.06.025
|
84 |
JL Nelles, WY Hu, GS Prins. Estrogen action and prostate cancer. Expert Rev Endocrinol Metab 2011; 6: 437–451
https://doi.org/10.1586/eem.11.20
|
85 |
D Gadelle, P Raibaud, E Sacquet. β-glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats. Appl Environ Microbiol 1985; 49(3): 682–685
pmid: 3994372
|
86 |
K Gloux, O Berteau, H Oumami, F Beguet, M Leclerc, J Dore. A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome. Proc Natl Acad Sci USA 2011; 108: 4539–4546
https://doi.org/10.1073/pnas.1000066107
|
87 |
DM Golombos, A Ayangbesan, P O’Malley, P Lewicki, L Barlow, CE Barbieri, C Chan, C DuLong, G Abu-Ali, C Huttenhower, DS Scherr. The role of gut microbiome in the pathogenesis of prostate cancer: a prospective, pilot study. Urology 2018; 111: 122–128
https://doi.org/10.1016/j.urology.2017.08.039
pmid: 28888753
|
88 |
SH Duncan, A Barcenilla, CS Stewart, SE Pryde, HJ Flint. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 2002; 68(10): 5186–5190
https://doi.org/10.1128/AEM.68.10.5186-5190.2002
pmid: 12324374
|
89 |
DW Cockburn, NI Orlovsky, MH Foley, KJ Kwiatkowski, CM Bahr, M Maynard, B Demeler, NM Koropatkin. Molecular details of a starch utilization pathway in the human gut symbiont Eubacterium rectale. Mol Microbiol 2015; 95(2): 209–230
https://doi.org/10.1111/mmi.12859
pmid: 25388295
|
90 |
HM Hamer, D Jonkers, K Venema, S Vanhoutvin, FJ Troost, RJ Brummer. The role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104–119
https://doi.org/10.1111/j.1365-2036.2007.03562.x
|
91 |
H Sokol, B Pigneur, L Watterlot, O Lakhdari, LG Bermúdez-Humarán, JJ Gratadoux, S Blugeon, C Bridonneau, JP Furet, G Corthier, C Grangette, N Vasquez, P Pochart, G Trugnan, G Thomas, HM Blottière, J Dorv, P Marteau, P Seksik, P Langella. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105(43): 16731–16736
https://doi.org/10.1073/pnas.0804812105
pmid: 18936492
|
92 |
M Kwa, CS Plottel, MJ Blaser, S Adams. The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst 2016; 22: 108
https://doi.org/10.1093/jnci/djw029
|
93 |
MA Hullar, AN Burnett-Hartman, JW Lampe. Gut microbes, diet, and cancer. Cancer Treat Res 2014; 159: 377–399
https://doi.org/10.1007/978-3-642-38007-5_22
pmid: 24114492
|
94 |
RF Schwabe, C Jobin. The microbiome and cancer. Nat Rev Cancer 2013; 13(11): 800–812
https://doi.org/10.1038/nrc3610
pmid: 24132111
|
95 |
AJ Price, RC Travis, PN Appleby, D Albanes, A Barricarte Gurrea, T Bjørge, et al.. Circulating folate and vitamin B12 and risk of prostate cancer: a collaborative analysis of individual participant data from six cohorts including 6875 cases and 8104 controls. Eur Urol 2016; 70: 941–951
https://doi.org/10.1016/j.eururo.2016.03.029
|
96 |
R Wang, Y Zheng, JY Huang, AQ Zhang, YH Zhou, JN Wang. Folate intake, serum folate levels, and prostate cancer risk: a meta-analysis of prospective studies. BMC Public Health 2014; 14: 1326
https://doi.org/10.1186/1471-2458-14-1326
|
97 |
I Cavarretta, R Ferrarese, W Cazzaniga, D Saita, R Lucianò, ER Ceresola, I Locatelli, L Visconti, G Lavorgna, A Briganti, M Nebuloni, C Doglioni, M Clementi, F Montorsi, F Canducci, A Salonia. The microbiome of the prostate tumor microenvironment. Eur Urol 2017; 72(4): 625–631
https://doi.org/10.1016/j.eururo.2017.03.029
pmid: 28434677
|
98 |
MA Liss, JR White, M Goros, J Gelfond, R Leach, T Johnson-Pais, Z Lai, E Rourke, J Basler, D Ankerst, DP Shah. Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer. Eur Urol 2018; 74(5): 575–582
https://doi.org/10.1016/j.eururo.2018.06.033
pmid: 30007819
|
99 |
SJ James, AG Basnakian, BJ Miller. In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res 1994; 54(19): 5075–5080
pmid: 7923120
|
100 |
SN Wickramasinghe, S Fida. Misincorporation of uracil into the DNA of folate- and B12-deficient HL60 cells. Eur J Haematol 1993; 50(3): 127–132
https://doi.org/10.1111/j.1600-0609.1993.tb00080.x
pmid: 8472808
|
101 |
SJ Duthie, A Hawdon. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 1998; 12(14): 1491–1497
https://doi.org/10.1096/fasebj.12.14.1491
pmid: 9806758
|
102 |
A Pompei, L Cordisco, A Amaretti, S Zanoni, D Matteuzzi, M Rossi. Folate production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol 2007; 73(1): 179–185
https://doi.org/10.1128/AEM.01763-06
pmid: 17071792
|
103 |
R Rodriguez-Melendez, JB Griffin, J Zempleni. Biotin supplementation increases expression of the cytochrome P450 1B1 gene in Jurkat cells, increasing the occurrence of single-stranded DNA breaks. J Nutr 2004; 134(9): 2222–2228
https://doi.org/10.1093/jn/134.9.2222
pmid: 15333708
|
104 |
FE Dewhirst, T Chen, J Izard, BJ Paster, AC Tanner, WH Yu, A Lakshmanan, WG Wade. The human oral microbiome. J Bacteriol 2010; 192(19): 5002–5017
https://doi.org/10.1128/JB.00542-10
pmid: 20656903
|
105 |
DS Michaud, J Izard, CS Wilhelm-Benartzi, DH You, VA Grote, A Tjønneland, CC Dahm, K Overvad, M Jenab, V Fedirko, MC Boutron-Ruault, F Clavel-Chapelon, A Racine, R Kaaks, H Boeing, J Foerster, A Trichopoulou, P Lagiou, D Trichopoulos, C Sacerdote, S Sieri, D Palli, R Tumino, S Panico, PD Siersema, PH Peeters, E Lund, A Barricarte, JM Huerta, E Molina-Montes, M Dorronsoro, JR Quirós, EJ Duell, W Ye, M Sund, B Lindkvist, D Johansen, KT Khaw, N Wareham, RC Travis, P Vineis, HB Bueno-de-Mesquita, E Riboli. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 2013; 62(12): 1764–1770
https://doi.org/10.1136/gutjnl-2012-303006
pmid: 22990306
|
106 |
JD Beck, S Offenbacher. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005; 76(11S): 2089–2100
https://doi.org/10.1902/jop.2005.76.11-S.2089
|
107 |
KJ Joshipura, EB Rimm, CW Douglass, D Trichopoulos, A Ascherio, WC Willett. Poor oral health and coronary heart disease. J Dent Res 1996; 75(9): 1631–1636
https://doi.org/10.1177/00220345960750090301
pmid: 8952614
|
108 |
S Offenbacher, HL Jared, PG O’Reilly, SR Wells, GE Salvi, HP Lawrence, SS Socransky, JD Beck. Potential pathogenic mechanisms of periodontitis associated pregnancy complications. Ann Periodontol 1998; 3(1): 233–250
https://doi.org/10.1902/annals.1998.3.1.233
pmid: 9722707
|
109 |
PP Hujoel, M Drangsholt, C Spiekerman, NS Weiss. An exploration of the periodontitis-cancer association. Ann Epidemiol 2003; 13(5): 312–316
https://doi.org/10.1016/S1047-2797(02)00425-8
pmid: 12821269
|
110 |
P Famili, JA Cauley, SL Greenspan. The effect of androgen deprivation therapy on periodontal disease in men with prostate cancer. J Urol 2007; 177(3): 921–924
https://doi.org/10.1016/j.juro.2006.10.067
pmid: 17296376
|
111 |
JN Krieger, L Nyberg Jr, JC Nickel. NIH consensus definition and classification of prostatitis. JAMA 1999; 282(3): 236–237
https://doi.org/10.1001/jama.282.3.236
pmid: 10422990
|
112 |
S Offenbacher. Periodontal diseases: pathogenesis. Ann Periodontol 1996; 1(1): 821–878
https://doi.org/10.1902/annals.1996.1.1.821
pmid: 9118282
|
113 |
TL Jang, AJ Schaeffer. The role of cytokines in prostatitis. World J Urol 2003; 21(2): 95–99
https://doi.org/10.1007/s00345-003-0335-2
pmid: 12783173
|
114 |
TE Van Dyke, AJ van Winkelhoff. Infection and inflammatory mechanisms. J Periodontol 2013; 84(4 Suppl): S1–S7
https://doi.org/10.1902/jop.2013.1340018
pmid: 23631571
|
115 |
N Joshi, NF Bissada, D Bodner, GT Maclennan, S Narendran, R Jurevic, R Skillicorn. Association between periodontal disease and prostate-specific antigen levels in chronic prostatitis patients. J Periodontol 2010; 81(6): 864–869
https://doi.org/10.1902/jop.2010.090646
pmid: 20450358
|
116 |
N Alwithanani, NF Bissada, N Joshi. Periodontal treatment improves prostate symptoms and lowers serum PSA in men with high PSA and chronic periodontitis. Dentistry 2015; 5: 1–4
https://doi.org/10.4172/2161-1122.1000284
|
117 |
Y Hasui, K Marutsuka, Y Asada, H Ide, S Nishi, Y Osada. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994; 25(2): 91–96
https://doi.org/10.1002/pros.2990250206
pmid: 7518599
|
118 |
E Kandirali, C Boran, E Serin, A Semercioz, A Metin. Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients. Urology 2007; 70(4): 743–747
https://doi.org/10.1016/j.urology.2007.06.1102
pmid: 17991548
|
119 |
B Noack, RJ Genco, M Trevisan, S Grossi, JJ Zambon, E De Nardin. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001; 72(9): 1221–1227
https://doi.org/10.1902/jop.2000.72.9.1221
pmid: 11577954
|
120 |
J Estemalik, C Demko, NF Bissada, N Joshi, D Bodner, E Shankar, S Gupta. Simultaneous detection of oral pathogens in subgingival plaque and prostatic fluid of men with periodontal and prostatic diseases. J Periodontol 2017; 88(9): 823–829
https://doi.org/10.1902/jop.2017.160477
pmid: 28548883
|
121 |
T Kadowaki, K Nakayama, F Yoshimura, K Okamoto, N Abe, K Yamamoto. Arg-gingipain acts as a major processing enzyme for various cell surface proteins in Porphyromonas gingivalis. J Biol Chem 1998; 273(44): 29072–29076
https://doi.org/10.1074/jbc.273.44.29072
pmid: 9786913
|
122 |
FR Saglie, A Marfany, P Camargo. Intragingival occurrence of Actinobacillus actinomycetemcomitans and Bacteroides gingivalis in active destructive periodontal lesions. J Periodontol 1988; 59(4): 259–265
https://doi.org/10.1902/jop.1988.59.4.259
pmid: 3290428
|
123 |
X Fan, AV Alekseyenko, J Wu, BA Peters, EJ Jacobs, SM Gapstur, MP Purdue, CC Abnet, R Stolzenberg-Solomon, G Miller, J Ravel, RB Hayes, J Ahn. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 2018; 67(1): 120–127
https://doi.org/10.1136/gutjnl-2016-312580
pmid: 27742762
|
124 |
PG Stathopoulou, MR Benakanakere, JC Galicia, DF Kinane. The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol 2009; 24(1): 11–17
https://doi.org/10.1111/j.1399-302X.2008.00467.x
pmid: 19121064
|
125 |
L Duncan, M Yoshioka, F Chandad, D Grenier. Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog 2004; 36(6): 319–325
https://doi.org/10.1016/j.micpath.2004.02.004
pmid: 15120158
|
126 |
SA Whiteside, H Razvi, S Dave, G Reid, JP Burton. The microbiome of the urinary tract—a role beyond infection. Nat Rev Urol 2015; 12(2): 81–90
https://doi.org/10.1038/nrurol.2014.361
pmid: 25600098
|
127 |
AJ Wolfe, E Toh, N Shibata, R Rong, K Kenton, M Fitzgerald, et al.. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 2012; 50: 1376–1383
https://doi.org/10.1128/JCM.05852-11
|
128 |
EE Hilt, K McKinley, MM Pearce, AB Rosenfeld, MJ Zilliox, ER Mueller, et al.. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 2014; 52: 871–876
https://doi.org/10.1128/JCM.02876-13
|
129 |
DA Lewis, R Brown, J Williams, P White, SK Jacobson, JR Marchesi, et al.. The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol 2013; 3: 41
https://doi.org/10.3389/fcimb.2013.00041
|
130 |
CM Porter, E Shrestha, LB Peiffer, KS Sfanos. The microbiome in prostate inflammation and prostate cancer. Prostate Cancer Prostatic Dis 2018; 21: 345–354
https://doi.org/10.1038/s41391-018-0041-1
|
131 |
RS Kirby, D Lowe, MI Bultitude, KE Shuttleworth. Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol 1982; 54(6): 729–731
https://doi.org/10.1111/j.1464-410X.1982.tb13635.x
pmid: 7150931
|
132 |
DE Fouts, R Pieper, S Szpakowski, H Pohl, S Knoblach, MJ Suh, et al.. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med 2012; 28: 174
https://doi.org/10.1186/1479-5876-10-174
|
133 |
DE Nelson, B Van Der Pol, Q Dong, KV Revanna, B Fan, S Easwaran, et al.. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS One 2010; 5: e14116
https://doi.org/10.1371/journal.pone.0014116
|
134 |
Q Dong, DE Nelson, E Toh, L Diao, X Gao, JD Fortenberry, et al.. The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS One 2011; 6: e19709
https://doi.org/10.1371/journal.pone.0019709
|
135 |
RJ Cohen, BA Shannon, JE McNeal, T Shannon, KL Garrett. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J Urol 2005; 173(6): 1969–1974
https://doi.org/10.1097/01.ju.0000158161.15277.78
pmid: 15879794
|
136 |
KS Sfanos, J Sauvageot, HL Fedor, JD Dick, AM De Marzo, WB Isaacs. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 2008; 68(3): 306–320
https://doi.org/10.1002/pros.20680
pmid: 18163428
|
137 |
TN Mak, SH Yu, AM De Marzo, H Brüggemann, KS Sfanos. Multi-locus sequence typing (MLST) analysis of Propionibacterium acnes isolates from radical prostatectomy specimens. Prostate 2013; 73: 770–777
https://doi.org/10.1002/pros.22621
|
138 |
KS Sfanos, WB Isaacs. An evaluation of PCR primer sets used for detection of Propionibacterium acnes in prostate tissue samples. Prostate 2008; 68: 1492–1495
https://doi.org/10.1002/pros.20820
|
139 |
S Davidsson, P Mölling, JR Rider, M Unemo, MG Karlsson, J Carlsson, et al.. Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infect Agent Cancer 2016; 11: 26
https://doi.org/10.1186/s13027-016-0074-9
|
140 |
CM Brede, DA Shoskes. The etiology and management of acute prostatitis. Nat Rev Urol 2011; 8: 207–212
https://doi.org/10.1038/nrurol.2011.22
|
141 |
M Sasaki, C Yamaura, Y Ohara-Nemoto, S Tajika, Y Kodama, T Ohya, R Harada, S Kimura. Streptococcus anginosus infection in oral cancer and its infection route. Oral Dis 2005; 11(3): 151–156
https://doi.org/10.1111/j.1601-0825.2005.01051.x
pmid: 15888105
|
142 |
K Shiga, M Tateda, S Saijo, T Hori, I Sato, H Tateno, K Matsuura, T Takasaka, T Miyagi. Presence of Streptococcus infection in extra-oropharyngeal head and neck squamous cell carcinoma and its implication in carcinogenesis. Oncol Rep 2001; 8(2): 245–248
https://doi.org/10.3892/or.8.2.245
pmid: 11182034
|
143 |
WF Fricke, C Maddox, Y Song, JS Bromberg. Human microbiota characterization in the course of renal transplantation. Am J Transplant 2014; 14: 416–427
https://doi.org/10.1111/ajt.12588
|
144 |
H Siddiqui, K Lagesen, AJ Nederbragt, SL Jeansson, KS Jakobsen. Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol 2012; 12: 205
https://doi.org/10.1186/1471-2180-12-205
|
145 |
AE Stapleton. Urinary tract infection pathogenesis: host factors. Infect Dis Clin North Am 2014; 28: 149–159
https://doi.org/10.1016/j.idc.2013.10.006
|
146 |
B Ragnarsdóttir, N Lutay, J Grönberg-Hernandez, B Köves, C Svanborg. Genetics of innate immunity and UTI susceptibility. Nat Rev Urol 2011; 8: 449–468
https://doi.org/10.1038/nrurol.2011.100
|
147 |
C Gottschick, ZL Deng, M Vital, C Masur, C Abels, DH Pieper, I Wagner-Döbler. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment. Microbiome 2017; 5: 99
https://doi.org/10.1186/s40168-017-0305-3
|
148 |
MM Pearce, EE Hilt, AB Rosenfeld, MJ Zilliox, K Thomas-White, C Fok, et al.. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. MBio 2014; 5: e01283–14
https://doi.org/10.1128/mBio.01283-14
|
149 |
V Nienhouse, X Gao, Q Dong, DE Nelson, E Toh, K McKinley, et al.. Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity. PLoS One 2014; 9: e114185
https://doi.org/10.1371/journal.pone.0114185
|
150 |
H Siddiqui, AJ Nederbragt, K Lagesen, SL Jeansson, KS Jakobsen. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol 2011; 11: 244
https://doi.org/10.1186/1471-2180-11-244
|
151 |
A Micheli, R Ciampichini, W Oberaigner, L Ciccolallo, E de Vries, I Izarzugaza, et al.. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009; 45: 1017–1027
https://doi.org/10.1016/j.ejca.2008.11.008
|
152 |
S Sutcliffe, JM Zenilman, KG Ghanem, RA Jadack, LJ Sokoll, DJ Elliott, et al.. Sexually transmitted infections and prostatic inflammation/cell damage as measured by serum prostate specific antigen concentration. J Urol 2006; 175: 1937–1942
https://doi.org/10.1016/S0022-5347(05)00892-X
|
153 |
WY Huang, R Hayes, R Pfeiffer, RP Viscidi, FK Lee, YF Wang, D Reding, D Whitby, JR Papp, CS Rabkin. Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17(9): 2374–2381
https://doi.org/10.1158/1055-9965.EPI-08-0173
pmid: 18768506
|
154 |
DA Shoskes, J Altemus, AS Polackwich, B Tucky, H Wang, C Eng. The urinary microbiome differs significantly between patients with chronic prostatitis/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 2016; 92: 26–32
https://doi.org/10.1016/j.urology.2016.02.043
pmid: 26970449
|
155 |
H Yu, H Meng, F Zhou, X Ni, S Shen, UN Das. Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia. Arch Med Sci 2015; 11(2): 385–394
https://doi.org/10.5114/aoms.2015.50970
pmid: 25995756
|
156 |
E Holmes, JV Li, T Athanasiou, H Ashrafian, JK Nicholson. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol 2011; 19: 349–359
https://doi.org/10.1016/j.tim.2011.05.006
|
157 |
AJ Cox, NP West, AW Cripps. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol 2015; 3: 207–215
https://doi.org/10.1016/S2213-8587(14)70134-2.
|
158 |
L Zitvogel, L Galluzzi, S Viaud, M Vétizou, R Daillère, M Merad, G Kroemer. Cancer and the gut microbiota: an unexpected link. Sci Transl Med 2015; 7(271): 271ps1
https://doi.org/10.1126/scitranslmed.3010473
pmid: 25609166
|
159 |
R Mandar. Microbiota of male genital tract: impact on the health of man and his partner. Pharmacol Res 2013; 69: 32–41
https://doi.org/10.1016/j.phrs.2012.10.019
|
160 |
S Keay, CO Zhang, BR Baldwin, RB Alexander. Polymerase chain reaction amplification of bacterial 16s rRNA genes in prostate biopsies from men without chronic prostatitis. Urology 1999; 53(3): 487–491
https://doi.org/10.1016/S0090-4295(98)00553-6
pmid: 10096371
|
161 |
JN Krieger, DE Riley, RL Vesella, DC Miner, SO Ross, PH Lange. Bacterial DNA sequences in prostate tissue from patients with prostate cancer and chronic prostatitis. J Urol 2000; 164(4): 1221–1228
https://doi.org/10.1016/S0022-5347(05)67145-5
pmid: 10992370
|
162 |
MA Yow, SN Tabrizi, G Severi, DM Bolton, J Pedersen; BioResource Australian Prostate Cancer, GG Giles, MC Southey. Characterisation of microbial communities within aggressive prostate cancer tissues. Infect Agent Cancer 2017; 12(1): 4
https://doi.org/10.1186/s13027-016-0112-7
pmid: 28101126
|
163 |
SJ Salter, MJ Cox, EM Turek, ST Calus, WO Cookson, MF Moffatt, et al.. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 2014; 12: 87
https://doi.org/10.1186/s12915-014-0087-z
|
164 |
A Glassing, SE Dowd, S Galandiuk, B Davis, RJ Chiodini. Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples. Gut Pathog 2016; 8(1): 24
https://doi.org/10.1186/s13099-016-0103-7
pmid: 27239228
|
165 |
M Alfano, F Canducci, M Nebuloni, M Clementi, F Montorsi, A Salonia. The interplay of extracellular matrix and microbiome in urothelial bladder cancer. Nat Rev Urol 2016; 13(2): 77–90
https://doi.org/10.1038/nrurol.2015.292
pmid: 26666363
|
166 |
S Caini, S Gandini, M Dudas, V Bremer, E Severi, A Gherasim. Sexually transmitted infections and prostate cancer risk: a systematic review and meta-analysis. Cancer Epidemiol 2014; 38: 329–338
https://doi.org/10.1016/j.canep.2014.06.002
|
167 |
BI Yoon, S Kim, DS Han, US Ha, SJ Lee, HW Kim, CH Han, YH Cho. Acute bacterial prostatitis: how to prevent and manage chronic infection? J Infect Chemother 2012; 18(4): 444–450
https://doi.org/10.1007/s10156-011-0350-y
pmid: 22215226
|
168 |
WR Fair, RF Parrish. Antibacterial substances in prostatic fluid. Prog Clin Biol Res 1981; 75A: 247–264
pmid: 7041133
|
169 |
SH Hall, KG Hamil, FS French. Host defense proteins of the male reproductive tract. J Androl 2002; 23(5): 585–597
pmid: 12185087
|
170 |
OA Alexeyev, I Marklund, B Shannon, I Golovleva, J Olsson, C Andersson, I Eriksson, R Cohen, F Elgh. Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay. J Clin Microbiol 2007; 45(11): 3721–3728
https://doi.org/10.1128/JCM.01543-07
pmid: 17881550
|
171 |
JB Drott, O Alexeyev, P Bergström, F Elgh, J Olsson. Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells. BMC Microbiol 2010; 10(1): 126–132
https://doi.org/10.1186/1471-2180-10-126
pmid: 20420679
|
172 |
ST Palayoor, MY Youmell, SK Calderwood, CN Coleman, BD Price. Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene 1999; 18(51): 7389–7394
https://doi.org/10.1038/sj.onc.1203160
pmid: 10602496
|
173 |
LB Mora, R Buettner, J Seigne, J Diaz, N Ahmad, R Garcia, T Bowman, R Falcone, R Fairclough, A Cantor, C Muro-Cacho, S Livingston, J Karras, J Pow-Sang, R Jove. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 2002; 62(22): 6659–6666
pmid: 12438264
|
174 |
L Fassi Fehri, TN Mak, B Laube, V Brinkmann, LA Ogilvie, H Mollenkopf, M Lein, T Schmidt, TF Meyer, H Brüggemann. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Int J Med Microbiol 2011; 301(1): 69–78
https://doi.org/10.1016/j.ijmm.2010.08.014
pmid: 20943438
|
175 |
S Ogino, R Nishihara, TJ VanderWeele, M Wang, A Nishi, P Lochhead, et al.. The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology 2016; 27(4): 602–611
https://doi.org/10.1097/EDE.0000000000000471
|
176 |
S Ogino, P Lochhead, AT Chan, R Nishihara, E Cho, BM Wolpin, et al.. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol 2013; 26(4): 465–484
https://doi.org/10.1038/modpathol.2012.214
|
177 |
PC Kashyap, N Chia, H Nelson, E Segal, E Elinav. Microbiome at the frontier of personalized medicine. Mayo Clin Proc 2017; 92(12): 1855–1864
https://doi.org/10.1016/j.mayocp.2017.10.004
|
178 |
T Hamada, JA Nowak, DA Jr Milner. M Song, S Ogino. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms. J Pathol 2019; 247(5): 615–628
https://doi.org/10.1002/path.5236
|
179 |
S Ogino, JA Nowak, T Hamada, DA Jr Milner, R Nishihara. Insights into pathogenic interactions among environment, host, and tumor at the crossroads of molecular pathology and epidemiology. Annu Rev Pathol 2019; 14: 83–103
https://doi.org/10.1146/annurev-pathmechdis-012418-012818
|
180 |
S Ogino, AT Chan, CS Fuchs, E Giovannucci. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011; 60: 397–411
https://doi.org/10.1136/gut.2010.217182
|
181 |
T Hamada, N Keum, R Nishihara, S Ogino. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol 2017; 52: 265–275
https://doi.org/10.1007/s00535-016-1272-3
|
182 |
NJ Whitaker, WK Glenn, A Sahrudin, MM Orde, W Delprado, JS Lawson. Human papillomavirus and Epstein Barr virus in prostate cancer: koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. Prostate 2013; 73(3): 236–241
https://doi.org/10.1002/pros.22562
|
183 |
YD Nam, HJ Kim, JG Seo, SW Kang, JW Bae. Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing. PLoS One 2013; 8(12): e82659
https://doi.org/10.1371/journal.pone.0082659
pmid: 24367534
|
184 |
S Banerjee, JC Alwine, Z Wei, T Tian, N Shih, C Sperling, et al.. Microbiome signatures in prostate cancer. Carcinogenesis 2019; 40(6): 749–764
https://doi.org/10.1093/carcin/bgz008
|
185 |
A Zambrano, M Kalantari, A Simoneau, JL Jensen, LP Villarreal. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 2002; 53(4): 263–276
https://doi.org/10.1002/pros.10157
|
186 |
RA Blaheta , E Weich , D Marian , J Bereiter-Hahn , J Jones , D Jonas , M Michaelis , HW Doerr , J Jr Cinatl . Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix. Neoplasia 2006; 8(10): 807–816
|
187 |
AP Bhatt, MR Redinbo, SJ Bultman. The role of the microbiome in cancer development and therapy. CA Cancer J Clin 2017; 67(4): 326–344
https://doi.org/10.3322/caac.21398
pmid: 28481406
|
188 |
ES Amirian, JF Petrosino, NJ Ajami, Y Liu, MP Mims, ME Scheurer. Potential role of gastrointestinal microbiota composition in prostate cancer risk. Infect Agent Cancer 2013; 8(1): 42
https://doi.org/10.1186/1750-9378-8-42
|
189 |
HJ Haiser, PJ Turnbaugh. Developing a metagenomic view of xenobiotic metabolism. Pharmacol Res 2013; 69(1): 21–31
https://doi.org/10.1016/j.phrs.2012.07.009
|
190 |
RJ Dutton, PJ Turnbaugh. Taking a metagenomic view of human nutrition. Curr Opin Clin Nutr Metab Care 2012; 15(5): 448–454
https://doi.org/10.1097/MCO.0b013e3283561133
|
191 |
NB La Thangue, DJ Kerr. Predictive biomarkers: a paradigm shift towards personalized cancer medicine. Nat Rev Clin Oncol 2011; 8(10): 587–596
https://doi.org/10.1038/nrclinonc.2011.121
|
192 |
SH Wong, TNY Kwong, CY Wu, J Yu. Clinical applications of gut microbiota in cancer biology. Semin Cancer Biol 2019; 55: 28– 36
https://doi.org/10.1016/j.semcancer.2018.05.003
pmid: 29782923
|
193 |
Y Shetty, P Prabhu, B Prabhakar. Emerging vistas in theranostic medicine. Int J Pharm 2019; 558: 29–42
https://doi.org/10.1016/j.ijpharm.2018.12.068
|
194 |
A Behrouzi, AH Nafari, SD Siadat. The significance of microbiome in personalized medicine. Clin Transl Med 2019; 8(1): 16
https://doi.org/10.1186/s40169-019-0232-y
|
195 |
S Alanee, A El-Zawahry, D Dynda, A Dabaja, K McVary, M Karr, et al.. A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis. Prostate 2019; 79(1): 81–87
https://doi.org/10.1002/pros.23713
|
196 |
Y Feng, W Jaratlerdsiri, SM Patrick, RJ Lyons, AM Haynes. CC Collins, et al.. Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African men. Prostate 2019; 79(15): 1731–1738
https://doi.org/10.1002/pros.23897
|
197 |
Y Feng, VR Ramnarine, R Bell, S Volik, E Davicioni. VM Hayes, et al.. Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer. BMC Genomics 2019; 20(1): 146
https://doi.org/10.1186/s12864-019-5457-z
|
198 |
X Ma, C Chi, L Fan, B Dong, X Shao, S Xie, et al.. The microbiome of prostate fluid is associated with prostate cancer. Front Microbiol 2019; 10: 1664
https://doi.org/10.3389/fmicb.2019.01664
|
199 |
D Rea, G Coppola, G Palma, A Barbieri, A Luciano, P Del Prete. Microbiota effects on cancer: from risks to therapies. Oncotarget 2018; 9(25): 17915–17927
https://doi.org/10.18632/oncotarget.24681
|
200 |
KM Wilson, EL Giovannucci, LA Mucci. Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl 2012; 14: 365–374
https://doi.org/10.1038/aja.2011.142
|
201 |
S Punnen, J Hardin, I Cheng, EA Klein, JS Witte. Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer. PLoS One 2011; 6: e27711
https://doi.org/10.1371/journal.pone.0027711
|
202 |
HL Newmark, RP Heaney. Dairy products and prostate cancer risk. Nutr Cancer 2010; 62: 297–299
https://doi.org/10.1080/01635580903407221
|
203 |
EL Richman, SA Kenfield, MJ Stampfer, EL Giovannucci, JM Chan. Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila) 2011; 4(12): 2110–2121
https://doi.org/10.1158/1940-6207.CAPR-11-0354
|
204 |
P Astorg. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 2004; 15: 367–386
https://doi.org/10.1023/B:CACO.0000027498.94238.a3
|
205 |
AD Joshi, R Corral, C Catsburg, JP Lewinger, J Koo, EM John, et al.. Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case–control study. Carcinogenesis 2012; 33: 2108–2118
https://doi.org/10.1093/carcin/bgs242
|
206 |
RC Travis, PN Appleby, A Siddiq, NE Allen, R Kaaks, F Canzian, et al.. Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition. Int J Cancer 2013; 132(8): 1901–1910
https://doi.org/10.1002/ijc.27836
|
207 |
ES Amirian, MM Ittmann, ME Scheurer. Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk. Prostate 2011; 71(13): 1382–1389
https://doi.org/10.1002/pros.21354
|
208 |
F Massari, V Mollica, V Di Nunno, L Gatto, M Santoni, M Scarpelli, et al.. The human microbiota and prostate cancer: friend or foe? Cancers (Basel) 2019; 11(4):459
https://doi.org/10.3390/cancers11040459
|
209 |
P Kundu, E Blacher, E Elinav, S Pettersson. Our gut microbiome: the evolving inner self. Cell 2017; 171(7): 1481–1493
https://doi.org/10.1016/j.cell.2017.11.024
|
210 |
M Blaser. Antibiotic overuse: stop the killing of beneficial bacteria. Nature 2011; 476(7361): 393–394
https://doi.org/10.1038/476393a
|
211 |
B Boursi, R Mamtani, K Haynes, YX Yang. Recurrent antibiotic exposure may promote cancer formation—another step in understanding the role of the human microbiota? Eur J Cancer 2015; 51(17): 2655–2664
https://doi.org/10.1016/j.ejca.2015.08.015
|
212 |
G Musso, R Gambino, M Cassader. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 2010; 33(10): 2277–2284
https://doi.org/10.2337/dc10-0556
|
213 |
V Iebba, M Nicoletti, S Schippa. Gut microbiota and the immune system: an intimate partnership in health and disease. Int J Immunopathol Pharmacol 2012; 25(4): 823–833
https://doi.org/10.1177/039463201202500401
|
214 |
JM Ridlon, S Ikegawa, JM Alves, B Zhou, A Kobayashi, T Iida, et al.. Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens. J Lipid Res 2013; 54(9): 2437–2449
https://doi.org/10.1194/jlr.M038869
|
215 |
JE Bisanz, MK Enos, JR Mwanga, J Changalucha, JP Burton, GB Gloor, et al.. Randomized open-label pilot study of the influence of probiotics and the gut microbiome on toxic metal levels in Tanzanian pregnant women and school children. MBio 2014; 5(5): e01580–1514
https://doi.org/10.1128/mBio.01580-14
|
216 |
S Maleki Vareki, RM Chanyi, K Abdur-Rashid, L Brennan, JP Burton. Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer. Ecancermedicalscience 2018; 12: 867
https://doi.org/10.3332/ecancer.2018.867
|
217 |
N Namasivayam. Chemoprevention in experimental animals. Ann N Y Acad Sci 2011; 1215: 60–71
https://doi.org/10.1111/j.1749-6632.2010.05873.x
|
218 |
R Flores, J Shi, B Fuhrman, X Xu, TD Veenstra, MH Gail, et al.. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med 2012; 10: 253
https://doi.org/10.1186/1479-5876-10-253
|
219 |
E Cavalieri, E Rogan. The molecular etiology and prevention of estrogeninitiated cancers. Mol Aspects Med 2014; 36: 1–55
https://doi.org/10.1016/j.mam.2013.08.002
|
220 |
H Akaza. Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the “second human genome”. Cancer Sci 2012; 103(6): 969–975
https://doi.org/10.1111/j.1349-7006.2012.02257.x
|
221 |
H Tsuji, K Moriyama, K Nomoto, N Miyanaga, H Akaza. Isolation and characterization of the equol-producing bacterium Slackia sp. Strain NATTS. Arch Microbiol 2010; 192(4): 279–287
https://doi.org/10.1007/s00203-010-0546-z
|
222 |
MI El-Demiry, TB Hargreave, A Busuttil, K James, AW Ritchie, GD Chisholm. Lymphocyte sub-populations in the male genital tract. Br J Urol 1985; 57(6): 769–774
https://doi.org/10.1111/j.1464-410X.1985.tb07051.x
pmid: 3910154
|
223 |
S McClinton, ID Miller, O Eremin. An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease. Br J Cancer 1990; 61(3): 400–403
https://doi.org/10.1038/bjc.1990.87
pmid: 1691655
|
224 |
N Iida, A Dzutsev, CA Stewart, L Smith, N Bouladoux, RA Weingarten, DA Molina, R Salcedo, T Back, S Cramer, RM Dai, H Kiu, M Cardone, S Naik, AK Patri, E Wang, FM Marincola, KM Frank, Y Belkaid, G Trinchieri, RS Goldszmid. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013; 342(6161): 967–970
https://doi.org/10.1126/science.1240527
pmid: 24264989
|
225 |
S Viaud, F Saccheri, G Mignot, T Yamazaki, R Daillère, D Hannani, et al.. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013; 342: 971–976
https://doi.org/10.1126/science.1240537
|
226 |
A Sivan, L Corrales, N Hubert, JB Williams, K Aquino-Michaels, ZM Earley, FW Benyamin, YM Lei, B Jabri, ML Alegre, EB Chang, TF Gajewski. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 2015; 350(6264): 1084–1089
https://doi.org/10.1126/science.aac4255
pmid: 26541606
|
227 |
TC Johnstone, GY Park, SJ Lippard. Understanding and improving platinum anticancer drugs—phenanthriplatin. Anticancer Res 2014; 34(1): 471–476
pmid: 24403503
|
228 |
B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, A Fluckiger, M Messaoudene, C Rauber, MP Roberti, M Fidelle, C Flament, V Poirier-Colame, P Opolon, C Klein, K Iribarren, L Mondragón, N Jacquelot, B Qu, G Ferrere, C Clémenson, L Mezquita, JR Masip, C Naltet, S Brosseau, C Kaderbhai, C Richard, H Rizvi, F Levenez, N Galleron, B Quinquis, N Pons, B Ryffel, V Minard-Colin, P Gonin, JC Soria, E Deutsch, Y Loriot, F Ghiringhelli, G Zalcman, F Goldwasser, B Escudier, MD Hellmann, A Eggermont, D Raoult, L Albiges, G Kroemer, L Zitvogel. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 2018; 359(6371): 91–97
https://doi.org/10.1126/science.aan3706
pmid: 29097494
|
229 |
V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, TV Karpinets, PA Prieto, D Vicente, K Hoffman, SC Wei, AP Cogdill, L Zhao, CW Hudgens, DS Hutchinson, T Manzo, M Petaccia de Macedo, T Cotechini, T Kumar, WS Chen, SM Reddy, R Szczepaniak Sloane, J Galloway-Pena, H Jiang, PL Chen, EJ Shpall, K Rezvani, AM Alousi, RF Chemaly, S Shelburne, LM Vence, PC Okhuysen, VB Jensen, AG Swennes, F McAllister, E Marcelo Riquelme Sanchez, Y Zhang, E Le Chatelier, L Zitvogel, N Pons, JL Austin-Breneman, LE Haydu, EM Burton, JM Gardner, E Sirmans, J Hu, AJ Lazar, T Tsujikawa, A Diab, H Tawbi, IC Glitza, WJ Hwu, SP Patel, SE Woodman, RN Amaria, MA Davies, JE Gershenwald, P Hwu, JE Lee, J Zhang, LM Coussens, ZA Cooper, PA Futreal, CR Daniel, NJ Ajami, JF Petrosino, MT Tetzlaff, P Sharma, JP Allison, RR Jenq, JA Wargo. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 2018; 359(6371): 97–103
https://doi.org/10.1126/science.aan4236
pmid: 29097493
|
230 |
RV Parry, JM Chemnitz, KA Frauwirth, AR Lanfranco, I Braunstein, SV Kobayashi, PS Linsley, CB Thompson, JL Riley. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005; 25(21): 9543–9553
https://doi.org/10.1128/MCB.25.21.9543-9553.2005
pmid: 16227604
|
231 |
BT Fife, KE Pauken, TN Eagar, T Obu, J Wu, Q Tang, M Azuma, et al.. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 2009; 10: 1185–1192
https://doi.org/10.1038/ni.1790
|
232 |
JN Graff, JJ Alumkal, CG Drake, GV Thomas, WL Redmond, M Farhad, JP Cetnar, FS Ey, RC Bergan, R Slottke, TM Beer. Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer. Oncotarget 2016; 7(33): 52810–52817
https://doi.org/10.18632/oncotarget.10547
pmid: 27429197
|
233 |
MP Kuczma, ZC Ding, T Li, T Habtetsion, T Chen, Z Hao, et al.. The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells. Oncotarget 2017; 8(67): 111931–111942
https://doi.org/10.18632/oncotarget.22953
|
234 |
J Vande Voorde, S Sabuncuoğlu, S Noppen, A Hofer, F Ranjbarian, S Fieuws, J Balzarini, S Liekens. Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine. J Biol Chem 2014; 289(19): 13054–13065
https://doi.org/10.1074/jbc.M114.558924
pmid: 24668817
|
235 |
S Ladoire, JC Eymard, S Zanetta, G Mignot, E Martin, I Kermarrec, E Mourey, F Michel, L Cormier, F Ghiringhelli. Metronomic oral cyclophosphamide prednisolone chemotherapy is an effective treatment for metastatic hormone-refractory prostate cancer after docetaxel failure. Anticancer Res 2010; 30(10): 4317–4323
pmid: 21036758
|
236 |
RS Kerbel, BA Kamen. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 2004; 4(6): 423–436
https://doi.org/10.1038/nrc1369
|
237 |
F Ghiringhelli, C Menard, PE Puig, S Ladoire, S Roux, F Martin, et al.. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T-cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 2007; 56(5): 641–648
https://doi.org/10.1007/s00262-006-0225-8
|
238 |
A Nicolini, P Mancini, P Ferrari, L Anselmi, G Tartarelli, V Bonazzi, et al.. Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC). Biomed Pharmacother 2004; 58(8): 447–450
https://doi.org/10.1016/j.biopha.2004.08.006
|
239 |
B Hellerstedt, KJ Pienta, BG Redman, P Esper, R Dunn, J Fardig, et al.. Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma. Cancer 2003; 98(8): 1603–1610
https://doi.org/10.1002/cncr.11686
|
240 |
S Bracarda, M Tonato, P Rosi, V De Angelis, E Mearini, S Cesaroni, P Fornetti, M Porena. Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study. Cancer 2000; 88(6): 1438–1444
https://doi.org/10.1002/(SICI)1097-0142(20000315)88:6<1438::AID-CNCR23>3.0.CO;2-O
pmid: 10717628
|
241 |
TC Johnstone, K Suntharalingam, SJ Lippard. The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs. Chem Rev 2016; 116(5): 3436–3486
https://doi.org/10.1021/acs.chemrev.5b00597
|
242 |
S Viaud, R Daillère, IG Boneca, P Lepage, P Langella, M Chamaillard, MJ Pittet, F Ghiringhelli, G Trinchieri, R Goldszmid, L Zitvogel. Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death Differ 2015; 22(2): 199–214
https://doi.org/10.1038/cdd.2014.56
pmid: 24832470
|
243 |
EL Westman, MJ Canova, IJ Radhi, K Koteva, I Kireeva, N Waglechner, et al.. Bacterial inactivation of the anticancer drug doxorubicin. Chem Biol 2012; 19(10): 1255–1264
https://doi.org/10.1016/j.chembiol.2012.08.011
|
244 |
N Harada, R Hanaoka, H Horiuchi, T Kitakaze, T Mitani, H Inui, R Yamaji. Castration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice. Sci Rep 2016; 6(1): 23001
https://doi.org/10.1038/srep23001
pmid: 26961573
|
245 |
M Fijlstra, M Ferdous, AM Koning, EH Rings, HJ Harmsen, WJ Tissing. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support Care Cancer 2015; 23(6): 1513– 1522
https://doi.org/10.1007/s00520-014-2487-6
|
246 |
KS Sfanos, MC Markowski, LB Peiffer, SE Ernst, JR White, KJ Pienta, et al.. Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer Prostatic Dis 2018; 21(4): 539–548
https://doi.org/10.1038/s41391-018-0061-x
|
247 |
HB Bode, B Zeggel, B Silakowski, SC Wenzel, H Reichenbach, R Müller. Steroid biosynthesis in prokaryotes: identification of myxobacterial steroids and cloning of the first bacterial 2,3(S)-oxidosqualene cyclase from the myxobacterium Stigmatella aurantiaca. Mol Microbiol 2003; 47: 471–481
https://doi.org/10.1046/j.1365-2958.2003.03309.x
|
248 |
V Matson, J Fessler, R Bao, T Chongsuwat, Y Zha, ML Alegre, JJ Luke, TF Gajewski. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 2018; 359(6371): 104–108
https://doi.org/10.1126/science.aao3290
pmid: 29302014
|
249 |
I Chitapanarux, T Chitapanarux, P Traisathit, S Kudumpee, E Tharavichitkul, V Lorvidhaya. Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 2010; 5(1): 31
https://doi.org/10.1186/1748-717X-5-31
pmid: 20444243
|
250 |
DV Seidel, MA Azcárate-Peril, RS Chapkin, ND Turner. Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk. Semin Cancer Biol 2017; 46: 191–204
https://doi.org/10.1016/j.semcancer.2017.06.009
|
251 |
MA Conlon, AR Bird. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 2014; 7(1): 17–44
https://doi.org/10.3390/nu7010017
|
252 |
M Vétizou, JM Pitt, R Daillère, P Lepage, N Waldschmitt, C Flament, S Rusakiewicz, B Routy, MP Roberti, CP Duong, V Poirier-Colame, A Roux, S Becharef, S Formenti, E Golden, S Cording, G Eberl, A Schlitzer, F Ginhoux, S Mani, T Yamazaki, N Jacquelot, DP Enot, M Bérard, J Nigou, P Opolon, A Eggermont, PL Woerther, E Chachaty, N Chaput, C Robert, C Mateus, G Kroemer, D Raoult, IG Boneca, F Carbonnel, M Chamaillard, L Zitvogel. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 2015; 350(6264): 1079–1084
https://doi.org/10.1126/science.aad1329
pmid: 26541610
|
253 |
F Guarner, JR Malagelada. Gut flora in health and disease. Lancet 2003; 361: 512–519
https://doi.org/10.1016/S0140-6736(03)12489-0
|
254 |
M Horinaka. T Yoshida, A Kishi, K Akatani, T Yasuda, J Kouhara, et al.. Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells. FEBS Lett 2010; 584(3): 577–582
https://doi.org/10.1016/j.febslet.2009.12.004
|
255 |
ME Sanders, TR Klaenhammer. The scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci 2001; 84: 319–331
https://doi.org/10.3168/jds.S0022-0302(01)74481-5
|
256 |
RG Montes, TM Bayless, JM Saavedra, JA Perman. Effect of milks inoculated with Lactobacillus acidophilus or a yogurt starter culture in lactosemaldigesting children. J Dairy Sci 1995; 78: 1657–1664
https://doi.org/10.3168/jds.S0022-0302(95)76790-X
|
257 |
D Davani-Davari, M Negahdaripour, I Karimzadeh, M Seifan, M Mohkam, SJ Masoumi, et al.. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods 2019; 8(3): 92
https://doi.org/10.3390/foods8030092
|
258 |
H Wang, MS Geier, GS Howarth. Prebiotics: a potential treatment strategy for the chemotherapy-damaged gut? Crit Rev Food Sci Nutr 2016; 56(6): 946–956
https://doi.org/10.1080/10408398.2012.741082
|
259 |
M Sambi, L Bagheri, MR Szewczuk. Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates. J Oncol 2019; 2019: 4508794
https://doi.org/10.1155/2019/4508794
|
260 |
M Arora, J Weuve, K Fall, NL Pedersen, LA Mucci. An exploration of shared genetic risk factors between periodontal disease and cancers: a prospective co-twin study. Am J Epidemiol 2010; 171(2): 253–259
https://doi.org/10.1093/aje/kwp340
|
261 |
M Miyake, K Ohnishi, S Hori, A Nakano, R Nakano, H Yano, et al.. Mycoplasma genitalium infection and chronic inflammation in human prostate cancer: detection using prostatectomy and needle biopsy specimens. Cells 2019; 8(3): 212
https://doi.org/10.3390/cells8030212
|
262 |
MS Al-Marhoon, A Ouhtit, AO Al-Abri, KP Venkiteswaran, Q Al-Busaidi, J Mathew, et al.. Molecular evidence of Helicobacter pylori infection in prostate tumors. Curr Urol 2015; 8(3): 138–143
https://doi.org/10.1159/000365705
|
263 |
S Alanee, A El-Zawahry, D Dynda, K McVary, M Karr, A Braundmeier-Fleming. Prospective examination of the changes in the urinary microbiome induced by transrectal biopsy of the prostate using 16S rRNA gene analy sis. Prostate Cancer Prostatic Dis 2019; 22(3): 446–452
https://doi.org/10.1038/s41391-018-0120-3.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|